Financials
Income statement
| Fiscal date | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
|---|---|---|---|---|
| Total reported revenue | 105.3K | 142.4K | 2.9M | 1.1M |
| Cost of revenue | 111.0K | 192.9K | 1.5M | 610.1K |
| Gross profit | -5.7K | -50.4K | 1.4M | 450.0K |
| Operating expense | ||||
| Research & development | 790.0K | 254.0K | 791.2K | 628.6K |
| Selling general and admin | 3.4M | 2.5M | 3.2M | 2.3M |
| Other operating expenses | — | — | — | — |
| Operating income | -4.3M | -3.0M | -2.8M | -2.7M |
| Non operating interest income | ||||
| Income | 40.0K | 78 | 4.8K | 11.0K |
| Expense | 46.6K | 31.6K | 90.9K | 59.9K |
| Other income expense | 683.5K | 1.4M | 1.2M | -421.0K |
| Pretax income | -3.6M | -1.6M | -3.5M | -3.2M |
| Tax provision | -9.1K | 22.3K | -184.7K | -179.1K |
| Net income | -3.6M | -1.6M | -3.7M | -3.0M |
| Basic EPS | -55.7 | -19.7 | — | -337.5 |
| Diluted EPS | -55.7 | -19.7 | — | -337.5 |
| Basic average shares | 89.6K | 111.7K | — | 12.5K |
| Diluted average shares | 89.6K | 111.7K | — | 12.5K |
| EBITDA | -4.1M | -2.8M | -4.2M | -2.7M |
| Net income from continuing op. | -3.6M | -1.6M | -3.7M | -3.0M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |